Fig. 1From: Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancerDifferences in the percentage of Akkermansiaceae among other bacterial families determined by the NGS method: a in different histopathological subtypes of NSCLC, b in groups of patients with different responses to immunotherapyBack to article page